0000899243-21-021824.txt : 20210603
0000899243-21-021824.hdr.sgml : 20210603
20210603172201
ACCESSION NUMBER: 0000899243-21-021824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alleva Lawrence M
CENTRAL INDEX KEY: 0001553053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 21993618
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 2 WEST LIBERTY BLVD #100
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-01
0
0001563577
Galera Therapeutics, Inc.
GRTX
0001553053
Alleva Lawrence M
C/O GALERA THERAPEUTICS, INC.,
2 W LIBERTY BLVD #100
MALVERN
PA
19355
1
0
0
0
Common Stock
2021-06-01
4
P
0
4045
8.5887
A
4045
I
By the Lawrence M. Alleva Revocable Trust.
Common Stock
6325
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.587 to $8.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Christopher Degnan, Attorney-in-Fact for Lawrence M. Alleva
2021-06-03